Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Cash from Operations (2016 - 2025)

Conmed (CNMD) has disclosed Cash from Operations for 16 consecutive years, with 46335000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 6.92% year-over-year to 46335000.0, compared with a TTM value of 170689000.0 through Dec 2025, up 2.23%, and an annual FY2025 reading of 170689000.0, up 2.23% over the prior year.
  • Cash from Operations was 46335000.0 for Q4 2025 at Conmed, down from 53686000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 56395000.0 in Q4 2023 and bottomed at 11598000.0 in Q4 2022.
  • Average Cash from Operations over 5 years is 30407000.0, with a median of 31459500.0 recorded in 2021.
  • The sharpest move saw Cash from Operations tumbled 1272.87% in 2023, then surged 856.98% in 2024.
  • Year by year, Cash from Operations stood at 33785000.0 in 2021, then crashed by 134.33% to 11598000.0 in 2022, then skyrocketed by 586.25% to 56395000.0 in 2023, then dropped by 23.15% to 43338000.0 in 2024, then rose by 6.92% to 46335000.0 in 2025.
  • Business Quant data shows Cash from Operations for CNMD at 46335000.0 in Q4 2025, 53686000.0 in Q3 2025, and 29134000.0 in Q2 2025.